These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 10421619

  • 1. Metabolism and excretion of atorvastatin in rats and dogs.
    Black AE, Hayes RN, Roth BD, Woo P, Woolf TF.
    Drug Metab Dispos; 1999 Aug; 27(8):916-23. PubMed ID: 10421619
    [Abstract] [Full Text] [Related]

  • 2. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM, D'Souza RA, Jordan AC, King CD, Smith SM, Phillips PJ, McCormick AD, Roberts DW.
    J Pharm Biomed Anal; 2007 Feb 19; 43(3):1065-77. PubMed ID: 17030109
    [Abstract] [Full Text] [Related]

  • 3. Metabolism and excretion studies in mouse after single and multiple oral doses of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin.
    Black AE, Sinz MW, Hayes RN, Woolf TF.
    Drug Metab Dispos; 1998 Aug 19; 26(8):755-63. PubMed ID: 9698289
    [Abstract] [Full Text] [Related]

  • 4. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
    Riska PS, Joseph DP, Dinallo RM, Davidson WC, Keirns JJ, Hattox SE.
    Drug Metab Dispos; 1999 Dec 19; 27(12):1434-47. PubMed ID: 10570025
    [Abstract] [Full Text] [Related]

  • 5. Metabolism and disposition of [14C]BMS-690514 after oral administration to rats, rabbits, and dogs.
    Hong H, Su H, Sun H, Allentoff A, Ekhato IV, Chando T, Caceres-Cortes J, Roongta V, Iyer RA, Humphreys WG, Christopher LJ.
    Drug Metab Dispos; 2010 Jul 19; 38(7):1189-201. PubMed ID: 20363952
    [Abstract] [Full Text] [Related]

  • 6. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
    Huskey SE, Dean BJ, Doss GA, Wang Z, Hop CE, Anari R, Finke PE, Robichaud AJ, Zhang M, Wang B, Strauss JR, Cunningham PK, Feeney WP, Franklin RB, Baillie TA, Chiu SH.
    Drug Metab Dispos; 2004 Feb 19; 32(2):246-58. PubMed ID: 14744948
    [Abstract] [Full Text] [Related]

  • 7. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans.
    Weinz C, Schwarz T, Kubitza D, Mueck W, Lang D.
    Drug Metab Dispos; 2009 May 19; 37(5):1056-64. PubMed ID: 19196845
    [Abstract] [Full Text] [Related]

  • 8. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C, Soliman V.
    Drug Metab Dispos; 1997 Nov 19; 25(11):1288-97. PubMed ID: 9351906
    [Abstract] [Full Text] [Related]

  • 9. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.
    Balani SK, Xu X, Pratha V, Koss MA, Amin RD, Dufresne C, Miller RR, Arison BH, Doss GA, Chiba M, Freeman A, Holland SD, Schwartz JI, Lasseter KC, Gertz BJ, Isenberg JI, Rogers JD, Lin JH, Baillie TA.
    Drug Metab Dispos; 1997 Nov 19; 25(11):1282-7. PubMed ID: 9351905
    [Abstract] [Full Text] [Related]

  • 10. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
    Zhang D, Wang L, Raghavan N, Zhang H, Li W, Cheng PT, Yao M, Zhang L, Zhu M, Bonacorsi S, Yeola S, Mitroka J, Hariharan N, Hosagrahara V, Chandrasena G, Shyu WC, Humphreys WG.
    Drug Metab Dispos; 2007 Jan 19; 35(1):150-67. PubMed ID: 17062777
    [Abstract] [Full Text] [Related]

  • 11. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats.
    Musser SM, Egorin MJ, Zuhowski EG, Hamburger DR, Parise RA, Covey JM, White KD, Eiseman JL.
    Cancer Chemother Pharmacol; 2003 Aug 19; 52(2):139-46. PubMed ID: 12761648
    [Abstract] [Full Text] [Related]

  • 12. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T, Nakajima Y, Mizobuchi M, Inazawa K, Kanazu T, Kadono K, Ohkawa T, Iwatani K.
    Arzneimittelforschung; 1998 Oct 19; 48(10):995-1006. PubMed ID: 9825117
    [Abstract] [Full Text] [Related]

  • 13. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.
    Halpin RA, Geer LA, Zhang KE, Marks TM, Dean DC, Jones AN, Melillo D, Doss G, Vyas KP.
    Drug Metab Dispos; 2000 Oct 19; 28(10):1244-54. PubMed ID: 10997947
    [Abstract] [Full Text] [Related]

  • 14. Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague-Dawley rats and beagle dogs. Effect of bile duct cannulation on excretion pathways.
    Dalvie DK, Khosla NB, Navetta KA, Brighty KE.
    Drug Metab Dispos; 1996 Nov 19; 24(11):1231-40. PubMed ID: 8937858
    [Abstract] [Full Text] [Related]

  • 15. Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.
    Halpin RA, Ulm EH, Till AE, Kari PH, Vyas KP, Hunninghake DB, Duggan DE.
    Drug Metab Dispos; 1993 Nov 19; 21(6):1003-11. PubMed ID: 7905377
    [Abstract] [Full Text] [Related]

  • 16. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs.
    Prakash C, Cui D, Potchoiba MJ, Butler T.
    Drug Metab Dispos; 2007 Aug 19; 35(8):1350-64. PubMed ID: 17496205
    [Abstract] [Full Text] [Related]

  • 17. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.
    Denissen JF, Grabowski BA, Johnson MK, Buko AM, Kempf DJ, Thomas SB, Surber BW.
    Drug Metab Dispos; 1997 Apr 19; 25(4):489-501. PubMed ID: 9107549
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Lau YY, Okochi H, Huang Y, Benet LZ.
    Drug Metab Dispos; 2006 Jul 19; 34(7):1175-81. PubMed ID: 16624870
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic and bioequivalence testing of atorvastatin formulations in healthy male volunteers.
    Mendoza L, Hajdúch M, Plausinaitis R, Platílová V, Emritte N, Svoboda M.
    Pharmazie; 2006 Sep 19; 61(9):805-6. PubMed ID: 17020163
    [Abstract] [Full Text] [Related]

  • 20. In vivo and in vitro metabolism studies on a class III antiarrhythmic agent.
    Vickers S, Duncan CA, Kari PH, Homnick CF, Elliott JM, Pitzenberger SM, Hichens M, Vyas KP.
    Drug Metab Dispos; 1993 Sep 19; 21(3):467-73. PubMed ID: 8100503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.